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Abstract
Objective. To produce consensus-based definitions of the US elementary lesions in gout and to test their
reliability in a web-based exercise.
Methods. The process consisted of two steps. In the first step a written Delphi questionnaire was de-
veloped from a systematic literature review and expert international consensus. This collated information
resulted in four statements defining US elementary lesions: double contour (DC), tophus, aggregates and
erosion. The Delphi questionnaire was sent to 35 rheumatology experts in US, asking them to rate their
level of agreement or disagreement with each statement. The second step tested the reliability by a web-
exercise. US images of both normal and gouty elementary lesions were collected by the participants. A
facilitator then constructed an electronic database of 110 images. The database was sent to the partici-
pants, who evaluated the presence/absence of US elementary lesions. A group of 20 images was dis-
played twice to evaluate intra-reader reliability.
Results. A total of 32 participants responded to the questionnaires. Good agreement (>80%) was ob-
tained for US definitions on DC, tophus, aggregates and erosion in the Delphi exercise after three rounds.
The reliability on images showed inter-reader  values for DC, tophus, aggregates, erosion findings of
0.98, 0.71, 0.54 and 0.85, respectively. The mean intra-reader  values were also acceptable: 0.93, 0.78,
0.65 and 0.78, respectively.
Conclusion. This, the first consensus-based US definition of elementary lesions in gout, demonstrated
good reliability overall. It constitutes an essential step in developing a core outcome measurement that
permits a higher degree of homogeneity and comparability between multicentre studies.
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Rheumatology key messages
. The results provide OMERACT consensus-based definitions of US gout lesions.
. The web-exercise reliability of US gout definitions showed overall good  values.
. This is the first step to ensure homogeneity and comparability between US multicentre studies in gout.
Introduction
Gout is an inflammatory disease induced by the precipi-
tation of MSU crystals in a variety of tissues, both inside
and around joints, where they can lead to acute or chronic
arthritis [1]. Its poor control can lead to renal failure,
cardiovascular disease, increased morbiditymortality
and poorer quality of life [2, 3].
Recent data suggest that gout affects up to 12.5% of
adults; however, its prevalence increases with age to rates
of up to 7% in men aged over 65 and 3% in women aged
over 85 [4, 5]. The treat-to-target approach is to lower
serum uric acid levels, allowing MSU crystals to dissolve,
leading to both the elimination of acute gouty attacks of
inflammation and the reduction of tophi formation [4].
However, despite new guidelines and recommendations
for diagnosis and management, and evolving new thera-
peutic options, suboptimal management of the disease is
still reported [4, 69]. Early detection and accurate diag-
nosis of gout play a crucial role in improving the outcome
of the disease, which is still a challenge in clinical daily
practice due to the great heterogeneity of the disease and
the non-specificity of symptoms in its early phases.
Imaging may play an important role, especially US, due
to its utility in both clinical practice and research activity
[1024]. It offers relevant properties such as direct visual-
ization of crystal deposits in the tissues, high sensitivity
in identifying early anatomical changes, and the ability to
determine therapy efficacy [21, 2326]. Additionally it
is patient friendly, safe and non-invasive, free of
ionizing radiation, less expensive, allows multiple-target
assessment in real time and can be performed at the
bedside.
To date, several studies supporting its accuracy, and
construct and criterion validity as well reliability in gout
have been published [15, 16, 21, 23, 24]. Interesting
data have also emerged from studies speculating about
its possible role in the very early diagnosis of the disease,
because US findings indicative of gout have also been
demonstrated in patients with asymptomatic hyperuricae-
mia [2730].
Despite the growing body of evidence supporting
the utility of US in gout, standardized definitions of the
elementary morphostructural changes and their reliability
have not been thoroughly established. Several authors
have developed and published definitions for US gout le-
sions, but the use of these definitions has been limited to
local clinical settings. In order to improve the use of US in
the evaluation of patients with gout and strengthen its
capability as an outcome instrument, an OMERACT US
Gout Task Force was formed.
The first aim of this study was to produce consensus-
based definitions of the US elementary lesions in gout
using a Delphi process among an international panel of
experts. The second aim was to test the inter- and intra-
reader reliability of the US definitions of each elementary
lesion in gout using a web-based exercise.
Methods
Study design
The OMERACT US Gout Task Force was formed and held
their first international meeting at the ACR congress in
2012. A systematic review of the literature was presented,
and relevant questions regarding the definition of gout
elementary lesions were discussed in order to plan the
Delphi exercise. A validation process was started and
the first two steps were defined for carrying out a Delphi
exercise on the US definitions of elementary lesions in
gout and for testing these definitions in an inter- and
intra-reader reliability web exercise. The institutional
ethics committee (Comitato Etico della Azienda Sanitaria
Unica Regionale di Ancona) approved the study, and
informed consent was obtained from patients scanned
for the inter- and intra-reader exercise.
First step: Delphi consensus on definition of gout
elementary US lesions
Thirty-five rheumatologists (experienced in both US and
gout) from 15 countries of Europe, America and
Australasia (Australia, Austria, Denmark, France,
Germany, Hungary, Ireland, Italy, Mexico, Netherlands,
Norway, Turkey, Spain, UK and USA) were identified.
The 35 experts were then emailed invitations to participate
in the Delphi consensus-building exercise.
A written Delphi questionnaire was constructed on the
basis of data collected from both the literature on US in
gout and discussion among OMERACT US Gout Task
Force members. The criteria presented for committee
scrutiny were assembled from PubMed and Medline
literature searches as well as from highly cited manu-
scripts on US in gout [1026]. Abstracts presented
at the 2012 ACR and EULAR scientific meetings were
also included. The previous definitions of US elementary
lesions described in the literature were used as a basis to
formulate the Delphi statements presented to the panel.
The first online survey that was sent to the participating
committee members consisted of 23 statements/items,
including definitions for: double contour (DC), synovitis,
tophus (intra-articular and intra-tendinous) and erosions
(supplementary Table S1, available at Rheumatology
Online). The names of the panellists were kept confidential
and all responses were re-identified prior to releasing
them to the group. This allowed each member to answer
questions without being influenced by the opinions of the
other panellists. The panel was asked to rate each item
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using a level of agreement or disagreement for each state-
ment according to a 15 Likert scale [31].
The answers from each Delphi questionnaire were
summarized with mean scores by a facilitator and
re-sent with a revised questionnaire to the panel for the
next round. The successive rounds consisted of new
surveys and included only the items that had achieved
significant agreement among the participants. An add-
itional criterion suggested by the panel during the first
interaction, as well as items that required rewording for
definitions, were included in the new survey.
Second step: inter- and intra-reader reliability web
exercise
The participants collected representative US images of
both normal and gouty elementary lesions agreed upon
during the preliminary Delphi process. Each participant
was asked to collect at least one US image of each indi-
vidual elementary lesion presented in the longitudinal and
transverse scans (Fig. 1). The anatomical sites requested
were as follows: knee (hyaline cartilage of the femoral
condyles; patellar tendon, including both proximal and
distal insertion; femoral bone profile), ankle (Achilles
tendon) and foot (first MTP joint for hyaline cartilage,
bone profile, periarticular tissue). These anatomical
areas were selected because of their accessibility by US
and their frequent involvement in patients with gout.
After a collection period of 1 month, the images were
sent by e-mail to a facilitator, who constructed an
electronic database of 110 images based on five findings
(1, DC; 2, tophus; 3, aggregates; 4, erosion; 5, no gouty
findings). It was re-sent to the participants, asking them to
read each image and determine the presence/absence of
the lesion by applying the definitions agreed in the first
step of the validation process. A randomly selected
group of 20 images was displayed twice in order to
assess intra-reader reliability.
Statistical analysis
In the Delphi process, the agreement was assessed
using a 15 Likert scale, which was graded as follows:
1, strongly disagree; 2, disagree; 3, neither agree nor
disagree; 4, agree; 5, strongly agree. Group agreement
with the issue under consideration was defined as total
cumulative agreement >80%. Only when sentences
achieved a score >80%, did we consider that the group
had reached a consensus and that the category was
defined as appropriate. Only the statements satisfying
these requirements were used for defining the definitive
elementary lesions.
Inter- and intra-reader reliability between the partici-
pants were estimated (by unweighted Cohen’s k-statistic)
in terms of dichotomous assessment (i.e. presence or
absence) and interpreted as follows: values of: 00.20
represent slight; 0.210.40 fair; 0.410.60 moderate;
0.610.80 substantial and >0.80 almost perfect reliability
[32]. Additionally, the 95% CIs were calculated. Statistical
analysis was performed using PROC GLIMMIX, applying
SAS software (v. 9.2; SAS Institute Inc., Cary, NC, USA).
Results
Delphi exercise
Thirty-two of 35 participants responded to the first Delphi
questionnaire (91% response rate). All 32 participants also
responded to the second and third rounds of the Delphi
questionnaire (100% response rate).
As previously mentioned, the first round of the Delphi
exercise included 23 statements regarding US elementary
lesions: DC, synovitis, tophi (intra-articular and intra-
tendinous) and erosions. Of the 23 statements with the
highest agreement, 11 were re-worded according to the
comments suggested in the first interaction and pre-
sented in the second round to the participants. The
panel agreed not to include synovitis among the elemen-
tary lesions of gout. Moreover, they suggested the term
aggregates rather than intra-tendinous tophus. Thus,
the elementary lesions included in the second Delphi ex-
ercise were: DC, aggregates independent of location (e.g.
extra-articular/intra-articular/intra-tendinous), tophus in-
dependent of location (e.g. extra-articular/intra-articular/
intra-tendinous) and erosions. Table 1 shows the total cu-
mulative agreement (percentage) for each statement of
the second round. After this, consensus for aggregates
and erosions (90% and 87%, respectively) was reached,
but no consensus was found for DC or tophus. A third and
final survey interaction was presented to the panel partici-
pants. It included a rewording of the definitions that did
not reach the 80% of consensus in the second round (DC
and tophus). Finally, a definitive consensus on four US
elementary lesions was reached after the third round,
with agreement for DC, aggregates, tophus and erosions
(91%, 90%, 81%, and 87%, respectively). The final defin-
itions were as follows:
DC: abnormal hyperechoic band over the superficial
margin of the articular hyaline cartilage, independent of
the angle of insonation and which may be either irregular
or regular, continuous or intermittent and can be distin-
guished from the cartilage interface sign.
Tophus [independent of location (e.g. extra-articular/
intra-articular/intra-tendinous)]: a circumscribed, inhomo-
geneous, hyperechoic and/or hypoechoic aggregation
(which may or may not generate posterior acoustic
shadow), which may be surrounded by a small anechoic
rim.
Aggregates [independent of location (intra-articular/
intra-tendinous)]: heterogeneous hyperechoic foci that
maintain their high degree of reflectivity, even when the
gain setting is minimized or the insonation angle is chan-
ged and which occasionally may generate posterior
acoustic shadow.
Erosion: an intra- and/or extra-articular discontinuity of
the bone surface (visible in two perpendicular planes).
Reliability of reading images
Of the 32 participants, 27 (84%) collected a total of 110
US images of the definitive elementary lesions including
the anatomical areas previously described. Twenty of
those 110 images were repeated twice for the assessment
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of intra-reader reliability. Ten additional normal US images
were included in the electronic system. The US equipment
used for image collections differed from institution to in-
stitution and comprised of the following: General Electric
Logiq 9 and E9, Esaote XVG, 60, 70 and Twice, Siemens
Antares, Phillips HDI 5000.
The observed agreement and the kappa coefficient
concerning inter and intra-reader reliability are listed in
Table 2. Both -values and 95% CI showed moderate to
almost perfect reliability between the investigators for all
the US elementary lesions. The lowest  values were ob-
tained for aggregates (0.54), whereas the best rate was for
DC (0.98). Similar results were obtained for the intra-
reader reliability, with the kappa coefficients ranging
from 0.65 to 0.93 (Table 2).
Discussion
A standardized US approach for patients with gout has
not yet been proposed, and there is still no international
consensus on the definitions of elementary lesions. This
was also underlined in a recent systematic literature
review, which showed non-uniformity in the definitions
being applied, and raised the necessity for a standardized
definition of US findings in gout [30]. Although important
advances in the care of gout have been achieved in recent
years, its management is far from optimal in either primary
care or rheumatology practice [69]; therefore, the quality
of assessment provided to gout patients needs to
improve.
US plays a key role in the management of these patients
as some of the elementary lesions are demonstrated to be
highly specific for the diagnosis [10, 14, 2125]. Its role
was also highlighted in the EULAR evidence-based rec-
ommendations for gout as a potential tool for diagnosis
and monitoring of gout [6, 7].
Taking into account the growing number of rheumatolo-
gists who are incorporating US into their research and
clinical assessment of gout, the development of a stan-
dardized approach is imperative. Therefore, the
OMERACT US Gout Task Force conducted a Delphi con-
sensus process and web-based reliability exercise in
order to obtain expert agreement on those elementary
lesions that should be included in the US definition of
gout and subsequently tested agreement on these defin-
itions on US images.
Three rounds of Delphi exercise were necessary to
reach an agreement on the definitive four US gout elem-
entary lesions highlighted in the literature review: DC, ag-
gregates, tophus and erosions. No agreement was
obtained for the inclusion of synovitis (including power
Doppler), which has been suggested by other authors in
previous papers. The main reasons for the disagreement
may include (i) the low specificity of these findings for gout
[33] since they are frequent in other inflammatory or de-
generative chronic arthropathies and (ii) the availability of
standardized definitions for this lesion, which were taken
as the reference for this exercise [34, 35]. However, we
aware that specific definitions for synovitis and tenosyno-
vitis for gout are needed, so this aspect will be part of a
FIG. 1 US findings of MSU deposits in a range of tissues
(A) Longitudinal suprapatellar scan with maximum knee flexion showing the double contour sign characterized by the
hyperechoic band over the superficial margin of the articular hyaline cartilage of the femoral condyle (arrow). (B) Knee.
Patellar tendon (t). Note the derangement of the normal fibrillar echotexture of the tendon caused by the aggregates of
MSU crystals. (C) Foot. First MTP joint showing an intra-articular tophus. Note the circumscribed, inhomogeneous,
hyperechoic aggregation, without acoustic shadow, surrounded by a small anechoic rim (arrow). (D) Foot. First MTP joint,
showing an intra-articular discontinuity of the bone surface (arrow). Note that B, C, D images show proximal on the right
and distal on the left. p: patella; pp: proximal phalanx; m: metatarsal head.
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forthcoming international meeting of the OMERACT US
Gout Task Force meeting and exercises on scoring and
sensitivity to change.
After the Delphi exercise, the web exercise tested inter-
and intra-reader reliability, showing good  values in all US
definitions. The range of  values for inter-observer
reliability was moderate to almost perfect (0.98, 0.71,
0.54, 0.85). Similar results were also detected for intra-
reader reliability. The US lesion with the highest level of
agreement among the participants was DC, whereas the
lowest level of agreement was found for aggregates,
which is in line with previous studies that tested the reli-
ability of US gout findings [22, 36]. One reason for the
overall good reliability for elementary lesions in gout
could be related to the type of image used in the web
exercise, which demonstrated typical and clear US find-
ings. On the other hand, there are possible explanations
for the relatively low level of agreement on aggregates.
The panel of US images used for the exercise included
aggregates with a range of levels of difficulty of detection
(as in daily practice); while large MSU aggregates could
be found easily, small crystal aggregates could be more
difficult to identify. Another reason could be related to the
use of only static images for the web exercise, rather than
video-dynamic clips, which may limit the global visualiza-
tion of the area of interest and the optimization of the US
images. Future exercises testing the US definitions on
patients are needed to establish whether this will hold
for clinical scanning, taking image acquisition into
account. In particular, the utility of a separate definition
of aggregates will be analysed on the basis of the results
of the reliability exercise on gouty patients (real-life scan-
ning). If aggregates are confirmed to have the lowest re-
liability, the possibility of merging the two definitions
(tophus and aggregates) will be considered. Another cru-
cial issue to solve is the use of the terminology tophus
because it is a histological concept as opposed to an
imaging description. Although several imaging studies of
US, MRI and CT [1015, 17, 19, 2123, 25, 37, 38] have
commonly adopted this term, we believe that further work
is needed in order to improve this lack of consensus in the
wider international community. Thus, the OMERACT US
Gout Task Force is planning studies involving close
collaboration with histologists in order to delineate a
common understanding of the terminology.
The present consensus for US lesions in gout requires
additional considerations. First, it represents the first step
of the OMERACT validation process of US definitions in
gout and is based on an international panel of US gout
experts with broad daily clinical and sonographic practice.
Second, the available evidence was appraised and sum-
marized following a rigorous approach and was combined
with the experience of several rheumatologists. Third, the
OMERACT gout US Task Force discussed largely the
details relating to the Delphi process and the way in
which propositions were developed. The Delphi approach
has several advantages: reduction in individual bias af-
forded by anonymity, equal weighting afforded to all
members, good external validity and ready identificationT
A
B
L
E
1
C
o
n
ti
n
u
e
d
S
ta
te
m
e
n
ts
ro
u
n
d
2
C
u
m
u
la
ti
v
e
a
g
re
e
m
e
n
t,
%
C
a
te
g
o
ry
a
p
p
ro
p
ri
a
te
d
S
ta
te
m
e
n
ts
ro
u
n
d
3
C
u
m
u
la
ti
v
e
a
g
re
e
m
e
n
t,
%
C
a
te
g
o
ry
a
p
p
ro
p
ri
a
te
d
In
h
o
m
o
g
e
n
e
o
u
s
h
y
p
e
re
c
h
o
ic
/h
y
p
o
e
c
h
o
ic
m
a
te
ri
a
l,
w
h
ic
h
m
a
y
g
e
n
e
ra
te
p
o
s
te
ri
o
r
a
c
o
u
s
ti
c
s
h
a
d
o
w
s
.
4
6
.8
N
o
E
ro
s
io
n
A
n
in
tr
a
-
a
n
d
/o
r
e
x
tr
a
-a
rt
ic
u
la
r
d
is
c
o
n
ti
n
u
it
y
o
f
th
e
b
o
n
e
s
u
rf
a
c
e
(v
is
ib
le
in
tw
o
p
e
rp
e
n
-
d
ic
u
la
r
p
la
n
e
s
).
8
4
Y
e
s
A
n
in
tr
a
-
a
n
d
/o
r
e
x
tr
a
-a
rt
ic
u
la
r
d
is
c
o
n
ti
n
u
it
y
o
f
th
e
b
o
n
e
s
u
rf
a
c
e
(v
is
ib
le
in
tw
o
p
e
rp
e
n
-
d
ic
u
la
r
p
la
n
e
s
)
th
a
t
m
a
y
b
e
a
s
s
o
c
ia
te
d
w
it
h
a
g
g
re
g
a
te
s
.
3
7
N
o
D
is
c
o
n
ti
n
u
it
y
o
f
th
e
b
o
n
e
s
u
rf
a
c
e
(v
is
ib
le
in
tw
o
p
e
rp
e
n
d
ic
u
la
r
p
la
n
e
s
)
th
a
t
m
a
y
b
e
a
c
c
o
m
p
a
n
ie
d
b
y
a
c
o
rt
ic
a
l
e
x
tr
a
-a
rt
ic
u
la
r
d
e
fe
c
t
a
n
d
m
a
y
a
s
s
o
c
ia
te
d
w
it
h
h
y
p
e
re
-
c
h
o
ic
c
lo
u
d
y
m
a
te
ri
a
l
w
it
h
in
th
e
e
ro
s
io
n
.
4
0
.6
N
o
1802 www.rheumatology.oxfordjournals.org
Marwin Gutierrez et al.
 at U
N
IV
ERSITA
 STU
D
I LA
 SA
PIEN
ZA
 on O
ctober 29, 2016
http://rheum
atology.oxfordjournals.org/
D
ow
nloaded from
 
of areas where more research data are required [39].
Fourth, the US definitions were corroborated by a reliabil-
ity exercise, which strengthens the reproducibility of the
agreed definitions. Finally, the high level of agreement
on the final US gout definitions and the multinational
participation increases their utility and will hopefully
facilitate their international dissemination and
implementation.
We are aware that some limitations are present in this
study. These are mainly related to the practicalities
common to these types of exercise, such as: whether
the aim should be the comprehensive coverage of all
options or rather a selective highlight of only key issues;
how best to edit and amalgamate statements submitted
in the first round; subsequent modifications to wording or
content of propositions to consider. An additional point to
consider is related to the fact that in order to improve
clarity, the Task Force undertook minor modifications
to the wording of some propositions at the end of the
process (after they had been researched, voted on
and fully discussed in a meeting held in Berlin), but
no change was made to the key content of the
propositions.
The next step in the validation process is to test the
definitions during scanning of gout patients and subse-
quently their diagnostic value in patients with gout and
undiagnosed gout in multicentre studies. Another limita-
tion is represented by the fact that only US images were
used to test the reliability. This type of modality, generally,
produces more reliable results with respect to US scan-
ning of patients. However the OMERACT US Gout Task
Force is currently conducting an exercise on patients in
order to obtain more accurate and reliable results for US
elementary lesions.
In conclusion, the results of this study provide prelimin-
ary consensus-based definitions of US gout lesions and
the first step in ensuring a higher degree of homogeneity
and comparability of results between studies and in daily
practice. Ongoing investigations testing their validity and
the responsiveness may strengthen these preliminary
definitions.
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